The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
2d
Hosted on MSNHims & Hers: From Viral Ad to Volatile StockHims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time ...
This year's Super Bowl commercials relied on comic relief and highlighted noncontroversial topics, like streaming and entertainment.
With Super Bowl 59 in the books, we wait for the unforgettable one-of-a-kind creativity of the commercials that aired during ...
Most of the commercials airing during this year's Super Bowl are going for laughs, with advertisers betting that America ...
A new barrage of new, glitzy, celebrity-filled ads debuted during Super Bowl 59 on Sunday. Fox, which airs the game, said in ...
At a time when every news alert seems to deliver a seismic jolt about the world, these ads mostly touch on safe subjects we ...
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ lobbying group, which says it’s “misleading” and potentially ...
A Super Bowl ad touting Hims & Hers Health Inc. ’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ lobbying group, which says it’s “misleading” and potentially violates ...
An advocacy group that includes the main pharmaceutical lobbying organization, PhRMA, as a member is complaining that a commercial Hims & Hers Health (NYSE:HIMS) is slated to run during the Super ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results